Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IL-13Rα1 is a glycosylated transmembrane protein that serves as a primary subunit of the interleukin-13 receptor complex. It forms functional receptor complexes with IL-4Rα, mediating signaling for both IL-13 and IL-4. It is expressed on a wide range of cell types and plays a central role in Th2-type immune responses, including allergic inflammation, and regulates processes like IgE class switching in B-cells. Dysregulation contributes significantly to diseases characterized by type II inflammation, such as asthma and atopic dermatitis. Therapeutics targeting this axis include monoclonal antibodies like dupilumab that block shared components such as the IL-4Rα subunit.
Dupilumab blocks the IL-4Rα subunit, thereby inhibiting signaling from both IL-4 and IL-13 through their common receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 13 Receptor Alpha 1 Subunit (IL-13Rα1).